Incidentaloma CT scan: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Incidentaloma}} {{CMG}}; {{AE}} ==Overview== There are no CT scan findings associated with [disease name]. OR [Location] CT scan may be helpful in the diagnos...")
 
No edit summary
Line 16: Line 16:


==CT scan==
==CT scan==
*There are no CT scan findings associated with [disease name].
OR
*[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include:
*[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include:
**[Finding 1]
*the density of the image is attributed to radiograph attenuation.  on nonenhanced CT
**[Finding 2]
*nonadenomas have higher attenuation in nonenhanced CT.
**[Finding 3]
*If an adrenal mass measures <10 HU on unenhanced CT (ie, has the density of fat), the likelihood that it is a benign adenoma is nearly 100 percent.
OR
*However, up to 30 percent of adenomas do not contain large amounts of lipid and may be indistinguishable from nonadenomas on nonenhanced CT scans.  A consensus panel noted that a homogeneous adrenal mass with a smooth border and an attenuation value <10 HU on unenhanced CT is very likely to be a benign adenoma [2]. This appears to be a reasonable CT HU cutoff based upon a retrospective analysis of 151 patients with adrenal masses who underwent both a noncontrast CT scan and adrenalectomy [17]. The mean HU (± standard deviation [SD]) for adrenal adenomas/hyperplasia was significantly lower than for adrenal carcinomas, metastases, and pheochromocytomas (16.2±13.6 versus 36.9±4.1, 39.2±15.2, and 38.6±8.2, respectively). The only patients in the nonadenoma groups with a noncontrast CT HU <10 were those with myelolipomas (which were all less than -40 and therefore easily distinguishable). In this series, a noncontrast CT HU ≤10 or a combination of tumor size ≤4 cm and HU ≤20 excluded nonadenomas in 100 percent of cases.  On delayed contrast-enhanced CT
*There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include:
*adenomas typically exhibit rapid contrast medium washout
**[Complication 1]
*nonadenomas have delayed contrast material washout [17].
**[Complication 2]
*Ten minutes after administration of contrast, an absolute contrast medium washout of more than 50 percent was reported to be 100 percent sensitive and specific for adenoma when patients with adenomas were compared with carcinomas, pheochromocytomas, and metastases [17-19].
**[Complication 3]
*Surgical resection should be considered in patients with adrenal incidentalomas that have a suspicious imaging phenotype [1].
 
*Contrast-enhanced washout CT utilizes the unique perfusion pattern of adenomas. Adenomas take up intravenous CT contrast rapidly, but also have a rapid loss of contrast – a phenomenon termed ‘contrast enhancement washout’. It is assumed that malignant adrenal lesions usually enhance rapidly but demonstrate a slower washout of contrast medium. This washout phenomenon can be quantified by ‘contrast washout values’, which involve lesion attenuation measurements at specific time points acquired in a dedicated adrenal CT: before injection of contrast medium (HU<sub>nativ</sub>), at 60s following injection of contrast medium (HU<sub>max</sub>) and then at 10 or 15min after contrast injection. This allows calculation of the relative contrast enhancement washout (=100×(HU<sub>max</sub>−HU<sub>10/15min</sub>)/HU<sub>max</sub>) and absolute contrast enhancement washout (=100×(HU<sub>max</sub>−HU<sub>10/15min</sub>)/(HU<sub>max</sub>−HU<sub>nativ</sub>)). A relative washout >40% and an absolute washout >60% is assumed to suggest that an adrenal lesion is benign (56, 58, 59, 60).
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 19:09, 21 August 2017

Incidentaloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Incidentaloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Incidentaloma CT scan On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Incidentaloma CT scan

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Incidentaloma CT scan

CDC on Incidentaloma CT scan

Incidentaloma CT scan in the news

Blogs on Incidentaloma CT scan

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Incidentaloma CT scan

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no CT scan findings associated with [disease name].

OR

[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

CT scan

  • [Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include:
  • the density of the image is attributed to radiograph attenuation. on nonenhanced CT
  • nonadenomas have higher attenuation in nonenhanced CT.
  • If an adrenal mass measures <10 HU on unenhanced CT (ie, has the density of fat), the likelihood that it is a benign adenoma is nearly 100 percent.
  • However, up to 30 percent of adenomas do not contain large amounts of lipid and may be indistinguishable from nonadenomas on nonenhanced CT scans. A consensus panel noted that a homogeneous adrenal mass with a smooth border and an attenuation value <10 HU on unenhanced CT is very likely to be a benign adenoma [2]. This appears to be a reasonable CT HU cutoff based upon a retrospective analysis of 151 patients with adrenal masses who underwent both a noncontrast CT scan and adrenalectomy [17]. The mean HU (± standard deviation [SD]) for adrenal adenomas/hyperplasia was significantly lower than for adrenal carcinomas, metastases, and pheochromocytomas (16.2±13.6 versus 36.9±4.1, 39.2±15.2, and 38.6±8.2, respectively). The only patients in the nonadenoma groups with a noncontrast CT HU <10 were those with myelolipomas (which were all less than -40 and therefore easily distinguishable). In this series, a noncontrast CT HU ≤10 or a combination of tumor size ≤4 cm and HU ≤20 excluded nonadenomas in 100 percent of cases. On delayed contrast-enhanced CT
  • adenomas typically exhibit rapid contrast medium washout
  • nonadenomas have delayed contrast material washout [17].
  • Ten minutes after administration of contrast, an absolute contrast medium washout of more than 50 percent was reported to be 100 percent sensitive and specific for adenoma when patients with adenomas were compared with carcinomas, pheochromocytomas, and metastases [17-19].
  • Surgical resection should be considered in patients with adrenal incidentalomas that have a suspicious imaging phenotype [1].
  • Contrast-enhanced washout CT utilizes the unique perfusion pattern of adenomas. Adenomas take up intravenous CT contrast rapidly, but also have a rapid loss of contrast – a phenomenon termed ‘contrast enhancement washout’. It is assumed that malignant adrenal lesions usually enhance rapidly but demonstrate a slower washout of contrast medium. This washout phenomenon can be quantified by ‘contrast washout values’, which involve lesion attenuation measurements at specific time points acquired in a dedicated adrenal CT: before injection of contrast medium (HUnativ), at 60s following injection of contrast medium (HUmax) and then at 10 or 15min after contrast injection. This allows calculation of the relative contrast enhancement washout (=100×(HUmax−HU10/15min)/HUmax) and absolute contrast enhancement washout (=100×(HUmax−HU10/15min)/(HUmax−HUnativ)). A relative washout >40% and an absolute washout >60% is assumed to suggest that an adrenal lesion is benign (56, 58, 59, 60).

References

Template:WH Template:WS